Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE

Approved

STANDARD

LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 5, 2022
Approval ID: 92c2a66f49355d5a
Company: Teva B.V.
Type: Standard

Approval Details

Approval Id: 92c2a66f49355d5a
Drug Cima Aemps Name: LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE
Register Number: 1130856004
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2022-10-05
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 6 MG/0,6 ML
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

Company Information

Pharmaceutical Company Name: Teva Pharma B.V.
Country Name: Netherlands
City Name: haarlem,noord-holland,country_nl
Address: Swensweg 5
Website: http://www.tevapharm.com

Active Ingredients

LIPEGFILGRASTIM

6 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 5, 2022

Approval ID

92c2a66f49355d5a

Type

Standard

Back to CIMA-AEMPS Approvals